Page last updated: 2024-11-04

dichloroisoproterenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dichloroisoproterenol: was heading 1968-94; was DICHLORISOPROTERENOL 1963-76; DCI was see DICHLOROISOPROTERENOL 1975-94; use ISOPROTERENOL to search DICHLOROISOPROTERENOL 1968-94 & DICHLORISOPROTERENOL 1966-67 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5806
CHEMBL ID30816
SCHEMBL ID613952
MeSH IDM0224665

Synonyms (40)

Synonym
dichloroisoproterenol,(+/-)
bdbm50036835
1-(3,4-dichloro-phenyl)-2-isopropylamino-ethanol
1-(3,4-dichloro-phenyl)-2-isopropylamino-ethanol(di chloroisoproterenol)
dichlorisoproterenol
beta-hydroxy-n-isopropyl-3,4-dichlorophenethylamine
3,4-dichlor-isoproterenol [german]
3,4-dichloro-alpha-(((1-methylethyl)amino)methyl)benzenemethanol
dichlorisoprenaline [german]
3,4-dichloro-alpha-(isopropylaminomethyl)benzyl alcohol
n-(beta-(3,4-dichlorophenyl)-beta-hydroxyethyl)isopropylamine
brn 2807251
benzyl alcohol, 3,4-dichloro-alpha-((isopropylamino)methyl)-
dichloroisoprenaline
PDSP1_000154
PDSP2_000153
59-61-0
dichloroisoproterenol
1-(3,4-dichlorophenyl)-2-isopropylaminoethanol
1-(3,4-dichlorophenyl)-2-(isopropylamino)ethanol
CHEMBL30816 ,
vkmgswifehzqrs-uhfffaoysa-
inchi=1/c11h15cl2no/c1-7(2)14-6-11(15)8-3-4-9(12)10(13)5-8/h3-5,7,11,14-15h,6h2,1-2h3
1-(3,4-dichlorophenyl)-2-(propan-2-ylamino)ethanol
AKOS009157165
dichlorisoprenaline
3,4-dichlor-isoproterenol
unii-u7noe2k4m2
u7noe2k4m2 ,
SCHEMBL613952
2-isopropylamino-1-(3,4-dichlorophenyl)-ethanol
VKMGSWIFEHZQRS-UHFFFAOYSA-N
2-isopropylamino-1-(3,4-dichlorophenyl)ethanol
(+/-)-dichlorisoproterenol
l-20522
benzenemethanol, 3,4-dichloro-.alpha.-(((1-methylethyl)amino)methyl)-
2350-05-2
DB12803
DTXSID20874225
Q387276
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (20)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-1 adrenergic receptor Cavia porcellus (domestic guinea pig)IC50 (µMol)0.11480.03470.07470.1148AID42037
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.507510.0000AID40714
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.507510.0000AID40714
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.507510.0000AID40714
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.505710.0000AID40714
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)IC50 (µMol)0.97720.00031.38338.4000AID40714
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.497310.0000AID40714
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.507510.0000AID40714
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.498810.0000AID40714
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.504610.0000AID40714
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.507510.0000AID40714
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.507510.0000AID40714
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.507510.0000AID40714
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.506510.0000AID40714
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.505710.0000AID40714
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.507510.0000AID40714
Beta-2 adrenergic receptor Bos taurus (cattle)Ki0.14000.00160.09040.1400AID40691
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)IC50 (µMol)0.97720.00040.16800.9772AID40714
GABA theta subunitRattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.507510.0000AID40714
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)IC50 (µMol)0.97720.00010.507510.0000AID40714
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (7)

Processvia Protein(s)Taxonomy
receptor-mediated endocytosisBeta-2 adrenergic receptor Bos taurus (cattle)
regulation of smooth muscle contractionBeta-2 adrenergic receptor Bos taurus (cattle)
positive regulation of MAPK cascadeBeta-2 adrenergic receptor Bos taurus (cattle)
negative regulation of G protein-coupled receptor signaling pathwayBeta-2 adrenergic receptor Bos taurus (cattle)
adenylate cyclase-activating adrenergic receptor signaling pathwayBeta-2 adrenergic receptor Bos taurus (cattle)
positive regulation of autophagosome maturationBeta-2 adrenergic receptor Bos taurus (cattle)
positive regulation of lipophagyBeta-2 adrenergic receptor Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
beta2-adrenergic receptor activityBeta-2 adrenergic receptor Bos taurus (cattle)
protein homodimerization activityBeta-2 adrenergic receptor Bos taurus (cattle)
norepinephrine bindingBeta-2 adrenergic receptor Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
early endosomeBeta-2 adrenergic receptor Bos taurus (cattle)
Golgi apparatusBeta-2 adrenergic receptor Bos taurus (cattle)
receptor complexBeta-2 adrenergic receptor Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID40405Binding affinity against beta-1-adrenergic receptor in rat brain1994Journal of medicinal chemistry, May-13, Volume: 37, Issue:10
The [(methyloxy)imino]methyl moiety as a bioisoster of aryl. A novel class of completely aliphatic beta-adrenergic receptor antagonists.
AID41488Selectivity for beta-2 adrenergic receptor1988Journal of medicinal chemistry, Nov, Volume: 31, Issue:11
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
AID205268Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex at 10 uM1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
AID26250Compound was evaluated for distribution coefficient1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
6,7-Dichloro-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline . A structurally novel beta-adrenergic receptor blocking agent.
AID15832Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
6,7-Dichloro-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline . A structurally novel beta-adrenergic receptor blocking agent.
AID41889Tested for intrinsic sympathomimetic activity (ISA); Antagonist with partial agonistic properties1988Journal of medicinal chemistry, Nov, Volume: 31, Issue:11
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
AID42037Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria1994Journal of medicinal chemistry, May-13, Volume: 37, Issue:10
The [(methyloxy)imino]methyl moiety as a bioisoster of aryl. A novel class of completely aliphatic beta-adrenergic receptor antagonists.
AID40537Selectivity for beta-1 adrenergic receptor1988Journal of medicinal chemistry, Nov, Volume: 31, Issue:11
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
AID205267Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
AID40691Binding affinity against beta-2-adrenergic receptor in bovine lung1994Journal of medicinal chemistry, May-13, Volume: 37, Issue:10
The [(methyloxy)imino]methyl moiety as a bioisoster of aryl. A novel class of completely aliphatic beta-adrenergic receptor antagonists.
AID40714Inhibitory concentration against beta-2-adrenergic receptor in isolated guinea pig tracheal strips1994Journal of medicinal chemistry, May-13, Volume: 37, Issue:10
The [(methyloxy)imino]methyl moiety as a bioisoster of aryl. A novel class of completely aliphatic beta-adrenergic receptor antagonists.
AID215614Dissociation constant against a series of agonists of membranes of the turkey erythrocyte containing mainly beta-adrenoceptors was determined.1982Journal of medicinal chemistry, Dec, Volume: 25, Issue:12
Correlation between affinity toward adrenergic receptors and approximate electrostatic potentials of phenylethylamine derivatives. 1. Effects of the side chain.
AID26765Partition coefficient (logP)1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
6,7-Dichloro-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline . A structurally novel beta-adrenergic receptor blocking agent.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (117)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990113 (96.58)18.7374
1990's1 (0.85)18.2507
2000's1 (0.85)29.6817
2010's2 (1.71)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.09 (24.57)
Research Supply Index4.84 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.60%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other123 (98.40%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]